Arxis, Inc. (ARXS) Stock Price & Analysis
Arxis, Inc. (ARXS) closed at USD 54.93 on Thursday, October 29, 2026, up 1.48% on the day. The US market is currently closed (after-hours); this is not a live price.
The prior close was USD 54.13; the Oct 29, 2026 session ranged USD 47.07–55.57 on volume of 2,070,875 shares. Market capitalization is $23.67B, with a 52-week range of USD 33.15–61.5 (NMS). Source: Nexqual, retrieved October 29, 2026 at 21:31 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ARXS.md
Latest Earnings Results (ARXS)
Arxis, Inc. (ARXS) reported Q3 2026 results on Oct 28, 2026, 4:05:00 PM ET: adjusted EPS $0.37 vs. estimate $0.29 (beat), revenue $564.00M vs. estimate $547.22M (beat). Guidance: The company raised its full-year 2026 revenue guidance to a range of $2,050 to $2,070 million. Source: company press release. Nexqual published it 2 min 5 s after release. Read the press release. Full report with estimates: nexqual.com/earnings/2026-10-28/ARXS.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $0.37 (adjusted (non-GAAP) diluted) | $564.0M | Oct 28, 2026, 4:05:00 PM ET · on Nexqual +2 min 5 s | PR Newswire |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (ARXS)
- Valuation: P/E 194.0x, EV/EBITDA 42.9x, net debt $1.23B.
- Analysts: Buy (mean 1.82 on a 1–5 scale) (11 analysts), mean target USD 63.7 (range 59–72).
- Total return with dividends: 1Y +41.8% vs S&P 500 +14.4%; 5Y +44.5% vs S&P 500 +79.1%.
- Next earnings: 2027-01-27, EPS estimate USD 0.29, revenue estimate $544M.
Valuation (price ÷ last four quarters, through Sep 30, 2026) (ARXS)
P/E 194.0x · P/S 12.2x · EV/EBITDA 42.9x · EV/Sales 12.8x · P/FCF 63.9x · FCF yield 1.57% · Earnings yield 0.52% · Net debt $1.23B · EV $24.9B
Analysts (ARXS)
Consensus Buy (mean 1.82 on a 1–5 scale), 11 analysts; mean target USD 63.7 (low 59, high 72).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-02 | RBC Capital | Upgrade | Sector Perform → Outperform | $50 → $60 |
| 2026-08-13 | Citigroup | Target raised | Buy | $61 → $67 |
| 2026-08-04 | Wells Fargo | Target raised | Overweight | $52 → $63 |
| 2026-07-31 | Citigroup | Target raised | Buy | $54 → $61 |
| 2026-07-31 | RBC Capital | Target raised | Sector Perform | $46 → $50 |
Total return (dividends reinvested) (ARXS)
| 1Y (from 2026-04-16) | 5Y (from 2026-04-13) | |
|---|---|---|
| Total return | +41.8% | +44.5% |
| S&P 500 (SPY) | +14.4% | +79.1% |
| Per year | — | — |
| Volatility (annualized) | 59.6% | 60.7% |
| Max drawdown | -22.0% (Aug 2026→Oct 2026) | -20.2% (Aug 2026→Oct 2026) |
ARXS earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Jul 29, 2026 | Quarter ended Jun 30, 2026 | $0.28 | $0.19 | Beat +47.4% | +11.2% |
| May 28, 2026 | Quarter ended Mar 31, 2026 | — | — | — | +13.0% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
ARXS recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 29, 2026 | 8-K/A | Current report |
| Oct 29, 2026 | 10-Q | Quarterly report · period ended Sep 30, 2026 |
| Oct 28, 2026 | 8-K | Current report |
| Oct 13, 2026 | S-1 | Registration of new shares |
| Sep 21, 2026 | Schedule 13G | Gerald W. Simonson Revocable Trust Agreement Dated May 12, 2016 as amended: 8.6% of shares, passive 5%+ holder |
| Aug 18, 2026 | 8-K | Completed an acquisition or sale of assets; Unregistered sale of shares “As previously disclosed in the Form 8-K filed with the Securities and Exchange Commission, on May 29, 2026, Arxis, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Orion Merger Sub, Inc., a Minnesota corporation and a wholly owned subsidiary of Arxis (the "Merger Sub"), Omnetics Connector Corporation, a Minnesota corporation ("Omnetics"), and Gary Jacobs, President of Omnetics, in his capacity as shareholder representative (the "Shareholder…” |
| Aug 14, 2026 | Schedule 13G | Engineered Components Borrower Series LP - Engineered Polymer Series, Engineered Components Borrower Series LP - Hawkeye Series: 81.8% of shares, passive 5%+ holder |
| Aug 12, 2026 | Schedule 13G | Capital Research Global Investors: 5.2% of shares, passive 5%+ holder |
| Aug 12, 2026 | Schedule 13G | Capital International Investors: 5.2% of shares, passive 5%+ holder |
| Jul 30, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Jul 29, 2026 | 8-K | Quarterly results |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
ARXS revenue by business segment (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Mechanical Components | $302.0M | 53.6% | +31.8% |
| Electronic Components | $261.9M | 46.4% | +41.1% |
| Total revenue | $564.0M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
ARXS company outlook (results filed Jul 29, 2026)
- “Free Cash Flow (1) of $127 million, up 261% Raising Full-Year 2026 Guidance (all comparisons against prior guidance midpoint, unless otherwise noted): ·”
Quoted word-for-word from the SEC 8-K results press release.
ARXS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.29 | $0.19 | +54.3% | $544.3M | 5 |
| Next quarter (ends Mar 2027) | $0.30 | $0.22 | +37.9% | $569.6M | 3 |
| Current fiscal year (ends Dec 2026) | $1.04 | $0.89 | +17.6% | $2.05B | 8 |
| Next fiscal year (ends Dec 2027) | $1.34 | $0.93 | +44.1% | $2.43B | 8 |
ARXS options: expected move
Options price a move of about ±29.2% (±$14.45) by Feb 19, 2027, which includes earnings on Jan 27, 2027. Over the last 2 reports the stock moved ±12.1% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 22 | 84.9% | ±20.4% |
| Dec 18, 2026 | 50 | 63.9% | ±20.9% |
| Feb 19, 2027 | 113 | 59.5% | ±29.2% |
| May 21, 2027 | 204 | 59.1% | ±37.7% |
30-day implied volatility 76.1% vs 43.9% realized over the last 30 trading days. Put/call ratio (volume) 0.71. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 21:31 UTC)
| Price | USD 54.93 |
|---|---|
| Change | ▲ 1.48% (up) |
| Previous Close | USD 54.13 |
| Open | USD 47.94 |
| Day Range | USD 47.07 – 55.57 |
| 52-Week Range | USD 33.15 – 61.5 |
| Volume | 2,070,875 shares |
| Market Cap | $23.67B |
| Exchange | NMS |
Technical Analysis (ARXS)
Nexqual's technical model rates ARXS "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 29, 2026 at 21:31 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.54 (neutral) |
| vs SMA50 | Above (USD 51.31) |
| MACD | 0.84 (positive) |
Analyst Ratings (ARXS)
Wall Street analysts rate ARXS "Buy" based on 11 analysts, with a mean price target of USD 63.7 (range USD 59–72), per Nexqual as of October 29, 2026 at 21:31 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 63.7 |
| High Target | USD 72 |
| Low Target | USD 59 |
| Buy / Hold / Sell | 11 / 0 / 0 |
Earnings (ARXS)
| Next Earnings Date | 2027-01-27 |
|---|---|
| EPS Estimate | USD 0.29 |
| Revenue Estimate | $544.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.37 vs est 0.29 ▲ beat |
| 2026-06-30 | USD 0.28 vs est 0.19 ▲ beat |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Financials & Fundamentals (ARXS)
| Total Revenue | $1.77B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +25.00% |
| Gross Margin | +52.35% |
| Operating Margin | +6.53% |
| Profit Margin | +7.23% |
| Debt / Equity | 0.4 |
| Current Ratio | 5.21 |
| Total Cash | $494.69M |
| Total Debt | $1.79B |
| Free Cash Flow (last four quarters to Sep 2026, SEC 10-Q / 10-K) | $370.48M (19.1% of revenue) |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Financial Health Score (ARXS)
Nexqual rates Arxis, Inc.'s overall financial health "Solid" across five dimensions, as of October 29, 2026 at 21:31 UTC.
| Growth | Strong — Revenue +25% YoY (latest Q) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 19% (last 4 quarters to Sep 2026, SEC) |
| Balance Sheet | Strong — $494M cash and investments vs $1.72B debt (Sep 2026, SEC) |
| Cash Flow | Strong — FCF $370M (last 4 quarters to Sep 2026, SEC), 19% margin |
| Efficiency | Mixed — ROE not meaningful (equity is not reported); ROA 1.5% (last 4 quarters, SEC) |
Ownership (ARXS)
| Insider Ownership | +13.61% |
|---|---|
| Institutional Ownership | +66.24% |
| Shares Outstanding | 90.15M |
| Float | 77.60M |
| Short % of Float | +6.52% |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Leadership (ARXS)
Arxis, Inc. is led by Kevin Scott Perhamus, President, CEO & Director, per Nexqual as of October 29, 2026 at 21:31 UTC.
| President, CEO & Director | Kevin Scott Perhamus |
|---|---|
| CFO & Treasurer | Azad Sid Badakhsh |
| President of Electronic Components | Jason Aaron Roth |
| President of Mechanical Components | Ross Bradley Sealfon |
Major Backers & Investors (ARXS)
Notable institutional backers of Arxis, Inc. include SmallCap World Fund Inc, T. Rowe Price, Jupiter Topco LLC, according to Nexqual as of October 29, 2026 at 21:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SmallCap World Fund Inc | 8.95% |
| T. Rowe Price | 5.7% |
| Jupiter Topco LLC | 5.02% |
| JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund | 4.18% |
| Capital International Investors | 4% |
| Capital Group | 3.99% |
| Price (T.Rowe) Associates Inc | 3.45% |
| Ameriprise Financial, Inc. | 2.95% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 2.44% |
| Vanguard Group | 2.07% |
Source: Nexqual, October 29, 2026 at 21:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FTAI | FTAI Aviation Ltd. | USD 196.01 | ▲ 17.27% |
| WWD | Woodward, Inc. | USD 314.92 | ▲ 3.57% |
| CW | Curtiss-Wright Corporation | USD 496.74 | ▲ 4.03% |
| AXON | Axon Enterprise, Inc. | USD 438.05 | ▲ 3.52% |
| TXT | Textron Inc. | USD 87.46 | ▲ 11.67% |
| ESLT | Elbit Systems Ltd. | USD 807.41 | ▲ 3.61% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 21:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt